Eduardo Bertolli

7PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2024
Emerging Indications for Neoadjuvant Systemic Therapies in Cutaneous Malignancies.

Domingos Sávio do Rego Lins Junior, Beatriz Mendes Awni Cidale, Ana Zelia Leal Pereira

|Jun 07, 2024
Brazilian Society of Surgical Oncology recommendations on Merkel cell carcinoma surgical treatment.

Matheus de Melo Lobo, Alberto Julius Alves Wainstein, Aldo Vieira Barros

|Oct 24, 2022
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma.

Rodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo

|Sep 16, 2022
A general class of promotion time cure rate models with a new biological interpretation.

Yolanda M Gómez, Diego I Gallardo, Marcelo Bourguignon

|Nov 04, 2020
Development and validation of a Brazilian nomogram to assess sentinel node biopsy positivity in melanoma.

Eduardo Bertolli, Vinicius F Calsavara, Mariana P de Macedo

Pageof 2